Awarded
4. Galkanezumab (N02CD02)
Original language: Czech
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- Avenier a.s.
- Contract value
- CZK 1,147,950
- Bids received
- 2
- Published
- 15 Oct 2026
- Awarded
- 16 Sept 2026
- Contract start
- 12 Aug 2026
- Contract end
- 25 Aug 2027estimated
- Region
- Zlínský kraj
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| I. Everolimus (ATC L01EG02) | Krajská nemocnice T. Bati, a. s. | Alliance Healthcare s.r.o. | CZK 485,772 | 26 Oct 2026 |
| IV. Omalizumab (ATC R03DX05) | Krajská nemocnice T. Bati, a. s. | PHOENIX lékárenský velkoobchod, s.r.o. | CZK 1,768,000 | 26 Oct 2026 |
| III. Nintedanib (ATC L01EX09) | Krajská nemocnice T. Bati, a. s. | PROMEDICA PRAHA GROUP, a.s. | CZK 1,186,842 | 26 Oct 2026 |
| II. Glatiramer-acetát (ATC L03AX13) | Krajská nemocnice T. Bati, a. s. | PROMEDICA PRAHA GROUP, a.s. | CZK 1,754,043 | 26 Oct 2026 |
| Dimethyl-fumarát (ATC L04AX07) | Krajská nemocnice T. Bati, a. s. | Alliance Healthcare s.r.o. | CZK 244,559 | 26 Oct 2026 |
| 5. Eptinezumab (N02CD05) | Krajská nemocnice T. Bati, a. s. | PHOENIX lékárenský velkoobchod, s.r.o. | CZK 772,759 | 15 Oct 2026 |